NCT05366608View on ClinicalTrials.gov

14.0- 3.0- 3.0- η Protein With Rheumatoid Arthritis

CompletedOBSERVATIONAL
Enrollment

188

Participants

Timeline

Start Date

January 1, 2019

Primary Completion Date

March 1, 2022

Study Completion Date

March 10, 2022

Conditions
Disease Activity
Interventions
DIAGNOSTIC_TEST

Serum level of 14.0- 3.0- 3.0- η protein and IL_.6

Serum level of 14.0- 3.0- 3.0- η protein and IL\_.6 were estimated for all participants by ELISA.

Trial Locations (1)

35516

Mansoura University, Al Mansurah

All Listed Sponsors
lead

Mansoura University

OTHER

NCT05366608 - 14.0- 3.0- 3.0- η Protein With Rheumatoid Arthritis | Biotech Hunter | Biotech Hunter